OncoMed Pharmaceuticals Inc.

(OMED) Trade

By |

Profile

OncoMed Pharmaceuticals Inc is a clinical development-stage biopharmaceutical company focused on discovering and developing novel anti-cancer stem cell and immuno-oncology product candidates.

Contact Information

Website: www.oncomed.com
Email: shari.annes@oncomed.com
Main Phone: +1 650 995-8200
Address: 800 Chesapeake Drive
State: CA
City / Town: Redwood City
Country: USA
Postal Code: 94063

Issuer Information

Exchange: NGS
CEO: John A. Lewicki
Employees: 56
NAICS: Pharmaceutical Preparation Manufacturing (325412)
$ 2.71 $ 0.11 (4.23%)
Last Price 2.71 Change $ 0.11 Change % 4.23 Tick N/A
Bid N/A Bid Size 0.00 Ask 4.90 Ask Size 100.00
Open 2.61 High 2.71 Low 2.61 Prev Close 2.60
Last Trade Volume 30,876 52 Wk Hi 5.56 52 Wk Low 1.74
Market Cap 104.1 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 38,431,086.00 EPS (TTM) -0.58 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 3 18
Number of Buys 0 5
Number of Sells 3 13
Net Activity -12659 138119
Last 10 Buys Shares
Perry A. Karsen 1,000
Jack W. Lasersohn 1,000
Jack W. Lasersohn 1,000
Jack W. Lasersohn 1,000
Jack W. Lasersohn 1,000
Jack W. Lasersohn 1,000
Jack W. Lasersohn 1,000
Jack W. Lasersohn 1,000
Jack W. Lasersohn 1,000
Jack W. Lasersohn 1,000
Last 10 Sell Shares
Austin Gurney 1,000
Alicia J. Hager 1,000
John A. Lewicki 1,000
Paul J. Hastings 1,000
Paul J. Hastings 1,000
Sunil Patel 1,000
Alicia J. Hager 1,000
John A. Lewicki 1,000
John A. Lewicki 1,000
Sunil Patel 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 8 8 8 8
Low Target Price Estimate 3 3 3 3
Mean Target Price Estimate 5.67 5.67 5.67 5.67
Standard Deviation 2.52 2.52 2.52 2.52
Date of Most Recent Estimate 05/09/18 05/09/18 05/09/18 05/09/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 0
Hold 1 1 2 4
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.67 1.67 2 2.33